HOLD - Texas Oncology, Dallas — Dallas, Texas

HOLD - Texas Oncology, Dallas is a clinical research site located in Dallas, Texas, United States 75230.

Crixeo Health Trust Score: 46/100 (POOR). This profile has not yet been claimed by the site owner.

HOLD - Texas Oncology, Dallas has participated in 1 clinical trials.

Therapeutic areas: Primary Myelofibrosis, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute.

Sponsors: Celgene.

Sponsor Feasibility Report

Trust Score: 46/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for HOLD - Texas Oncology, Dallas?

HOLD - Texas Oncology, Dallas has a Crixeo Trust Score of 46/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has HOLD - Texas Oncology, Dallas conducted?

HOLD - Texas Oncology, Dallas has 1 clinical trials on record. Their work covers Primary Myelofibrosis, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute.

Is HOLD - Texas Oncology, Dallas accredited by Crixeo Health?

HOLD - Texas Oncology, Dallas has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about HOLD - Texas Oncology, Dallas?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.